Personalized medicines are transforming treatments and outcomes for some women with ovarian cancer, with potential to help many more. Yet, for all these, we know that access can be erratic, disproportionate, and even non-existent for patients and their physicians. Affordable access to quality, multimodal treatments, essential medicines, technologies, and surgical oncology must be improved to achieve a standard level and extent of care, aligning and improving available resource with evidence-based clinical guidelines for ovarian cancer.
Teckro is a sponsor of this virtual conference hosted by the World Ovarian Cancer Coalition. The event will look at:
The event will appeal to a wide range of participants including patient advocacy organizations, global and national health policy organizations, clinicians, researchers, and those involved in new and emerging ovarian cancer treatments.
Details of registration and more information to follow.